Jeffrey Fudin

8PUBLICATIONS
6CO-AUTHORS
Pharmaceutical delivery technologiesPharmacology and pharmaceutical sciences not elsewhere classifiedPredictive and prognostic markersHealth psychologyFine arts
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2022
Open-Label Adhesion Performance Study of a Prescription Lidocaine Topical System 1.8% versus Three Lidocaine-Containing Over-the-Counter Patches in Healthy Subjects.

Jeffrey Fudin, Kip Vought, Kalpana Patel

|Apr 13, 2022
Misinterpretation of the "Overdose Crisis" Continues to Fuel Misunderstanding of the Role of Prescription Opioids.

Jeffrey J Bettinger, William Amarquaye, Jeffrey Fudin

|Oct 28, 2021
Opioid Taper Practices Among Clinicians.

Amelia L Persico, Jeffrey J Bettinger, Erica L Wegrzyn

|Nov 06, 2020
The Repeal of the Affordable Care Act and Its Likely Impact on Chronic Pain Patients: "Have You No Shame?"

Michael E Schatman, Hannah Shapiro, Jeffrey Fudin

|Sep 09, 2020
Fentalogues.

Amelia L Persico, Erica L Wegrzyn, Jeffrey Fudin

|Jul 02, 2020
A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects.

Jeffrey Gudin, Charles Argoff, Jeffrey Fudin

Pageof 2

Frequent Collaborators

3 joint publications

Michael E Schatman

2 joint publications

Emileigh Greuber

1 joint publications

Jeffrey Gudin

1 joint publications

Amelia L Persico